Pfizer – Mental Health in Rheumatology – Request for Proposals (RFP)
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire within unit
Memorial Deadline: Thursday 30th, March 2023
External Deadline: Thursday 6th, April 2023
Description
| Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP. For all independent quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program. |
| Date RFP Issued: February 8, 2023
Geographic Scope: Canada Clinical Area: Rheumatology Link to full RFP: Mental Health in Rheumatology Application Due Date: April 6, 2023 Specific Area of Interest: This competitive grant program seeks to address patient mental health in rheumatology considering values of diversity, equity, and inclusion. Quality improvement (QI) Projects that will be considered for Pfizer support will focus on improving access and care for rheumatology patients affected by mental health issues, through the implementation of innovative solutions aimed at:
|